未登录Phase 2 trial of imprime and pembrolizumab immunotherapy in metastatic triple negative breast cancer patients who have progressed beyond first line chemotherapy二线化疗进展后的转移性三阴性乳腺癌患者中Imprime与Pembrolizumab免疫疗法的二期临床试验
Stopeck, Alison T.; Abu-Khalaf, Maysa; Borges, Virginia; Chmielowski, Bartosz; Rao, Ruta; Xie, Bin; Dudek, Arkadiusz Z.; Mina, Lida; O'Shaughnessy, Joyce; Chisamore, Michael; Mattson, Paulette; Gargano, Michele; Cox, Joanna; Osterwalder, Bruno; Drees, Jeremy; Harrison, Ben; Chan, Anissa S. H.; Qiu, Xiaohong; Ottoson, Nadine; Bose, Nandita; Uhlik, Mark; Graff, Jeremy; Iglesias, Jose
分享
收藏
分享
收藏Circulating tumor DNA (ctDNA) monitoring of estrogen receptor-positive, human epidermal growth factor receptor 2-negative (ER+/HER2-) high risk breast cancer during adjuvant endocrine therapy
Pusztai, Lajos; Kalashnikova, Ekaterina; Hobbs, Evthokia; Brown-Glaberman, Ursa; Mita, Monica; Klein, Paula; Yan, Fengting; Ehsani, Sima; Razaq, Wajeeha; Stopeck, Alison; Bhave, Manali; Loch, Michelle; Sardesai, Sagar; Torres, Evanthia Roussos; Burkard, Mark; Okubanjo, Femi; Gauthier, Eric; Rodriguez, Angel; Liu, Minetta; Kabos, Peter
分享
收藏Correlation between collagen peptides and physical features of fibrosis in breast tissue from women at increased risk of cancer
Rujchanarong, Denys; Stopeck, Alison T.; Preece, Christina; Sun, Ren; Chalasani, Pavani; Brown, Sean; Bai, Ji D.; Smith, Heather Jensen; You, Sungyong; Angel, Peggi M.; Thompson, Patricia
分享
收藏
分享
收藏
分享
收藏Two fully automated data-driven 3D whole-breast segmentation strategies in MRI for MR-based breast density using image registration and U-Net with a focus on reproducibility
Ying, Jia; Cattell, Renee; Zhao, Tianyun; Lei, Lan; Jiang, Zhao; Hussain, Shahid M.; Gao, Yi; Chow, H-H Sherry; Stopeck, Alison T.; Thompson, Patricia A.; Huang, Chuan
分享
收藏
分享
收藏
分享
收藏Experience with denosumab (XGEVA®) for prevention of skeletal-related events in the 10 years after approval
Cadieux, Benoit; Coleman, Robert; Jafarinasabian, Pegah; Lipton, Allan; Orlowski, Robert Z.; Saad, Fred; Scagliotti, Giorgio, V; Shimizu, Kazuyuki; Stopeck, Alison
分享
收藏
分享
收藏Intracranial efficacy of tucatinib, palbociclib and letrozole combination in patients with HR+/HER2+breast cancer and brain metastases
Shagisultanova, Elena; Gradishar, William; Brown-Glaberman, Ursa; Chalasani, Pavani; Brenner, Andrew; Stopeck, Alison; Mayordomo, Jose; Diamond, Jennifer; Kabos, Peter; Borges, Virginia F.
分享
收藏
分享
收藏
分享
收藏
分享
收藏IMPRIME 1 (NCT02981303): A novel phase 2 study in second-line plus , metastatic triple negative breast cancer patients shows promising clinical benefit for the combination of the immune checkpoint inhibitor, pembrolizumab (pembro), with the novel innate immune activator, Imprime PGG
O'Day, Steven J.; Borges, Virginia F.; Chmielowski, Bartosz; Rao, Ruta D.; Abu-Khalaf, Maysa; Stopeck, Alison; O'Shaughnessy, Joyce A.; Chisamore, Michael; Karantza, Vassiliki; Cox, Joanna; Mattson, Paulette; Gargano, Michele A.; Osterwalder, Bruno; Uhlik, Mark; Bose, Nandita; Graff, Jeremy
分享
收藏
分享
收藏Response and clinical benefit assessment of the combination of the dectin-1 agonist imprime PGG and anti-PD-1 pembrolizumab in chemotherapy-resistant metastatic triple negative breast cancer (TNBC)
Uhlik, Mark T.; Bose, Nandita; Cox, Joanna; Mattson, Paulette; Gargano, Michele; O'Day, Stephen; Borges, Virginia; Chmielowski, Bartosz; Rao, Ruta; Abu-Khalaf, Maysa; Stopeck, Alison; Chisamore, Michael; Osterwalder, Bruno; Graff, Jeremy
分享
收藏
分享
收藏
分享
收藏